CELLULAR AND MOLECULAR LIFE SCIENCES-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=799498, encodeId=b82ae9949840, content=请问这个杂志，编辑修改了格式错误，再次提交要多久能到编辑手里？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Tue Jun 23 21:21:38 CST 2020, time=2020-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189423, encodeId=3331218942342, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:31:22 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2189422, encodeId=8f662189422c1, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:30:58 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2188268, encodeId=fb5d2188268e4, content=请问大家，这个杂志有几个reviewer , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53008499251, createdName=ms2000000711984129, createdTime=Tue Feb 20 10:33:54 CST 2024, time=2024-02-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2107698, encodeId=9864210e698c3, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：细胞;分子生物;肌肉 经验分享：2022-10-30 submission 2022-10-31 with editor 2022-11-9 under review 2022-12-6 Minor revision, 2022-12-16 revised 2022-12-19 accept 审稿人意见很精辟，对内容把控的也很细致, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1de26577218, createdName=ms3000001732307962, createdTime=Tue Dec 27 17:28:23 CST 2022, time=2022-12-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1248958, encodeId=1da1124895855, content=9.9 submission，9.12 with editor，目前还没有变化，希望在编辑手里一周能出结果，要么under review，要么reject/transfer, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da445615235, createdName=ms3000000389846462, createdTime=Wed Sep 14 21:54:55 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234996, encodeId=ff93123499659, content=请问，submitted to the journal 需要几天才能改变状态？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Wed Jul 27 08:44:41 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234567, encodeId=a0fb123456e1b, content=请问，submitted to the journal 需要几天呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Mon Jul 25 11:30:44 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055110, encodeId=4df21055110f6, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：核膜;血管新生 经验分享：做蛋白新表型研究的，也有敲除动物，个人觉得做得蛮全面的，就是深度可能不够。 审稿速度正常，投稿到有review意见1个半月。 两个review细致专业，给的意见估计是大修，第二个review明显态度很积极。一共5页审稿意见，有一些也不难补，有一些是表述问题，不需要补实验。但editor估计没仔细看，就觉得要补的太多，没给机会。 所以感觉对国人不太友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23305505580, createdName=ms3000001738384174, createdTime=Sun Sep 26 20:54:06 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013517, encodeId=59fd101351e6a, content=没投过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb672316488, createdName=1223a67dm56(暂无昵称), createdTime=Wed Sep 01 17:06:03 CST 2021, time=2021-09-01, status=1, ipAttribution=)]

2020-06-23 ms9000001460504456

请问这个杂志，编辑修改了格式错误，再次提交要多久能到编辑手里？

144 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=799498, encodeId=b82ae9949840, content=请问这个杂志，编辑修改了格式错误，再次提交要多久能到编辑手里？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Tue Jun 23 21:21:38 CST 2020, time=2020-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189423, encodeId=3331218942342, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:31:22 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2189422, encodeId=8f662189422c1, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:30:58 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2188268, encodeId=fb5d2188268e4, content=请问大家，这个杂志有几个reviewer , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53008499251, createdName=ms2000000711984129, createdTime=Tue Feb 20 10:33:54 CST 2024, time=2024-02-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2107698, encodeId=9864210e698c3, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：细胞;分子生物;肌肉 经验分享：2022-10-30 submission 2022-10-31 with editor 2022-11-9 under review 2022-12-6 Minor revision, 2022-12-16 revised 2022-12-19 accept 审稿人意见很精辟，对内容把控的也很细致, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1de26577218, createdName=ms3000001732307962, createdTime=Tue Dec 27 17:28:23 CST 2022, time=2022-12-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1248958, encodeId=1da1124895855, content=9.9 submission，9.12 with editor，目前还没有变化，希望在编辑手里一周能出结果，要么under review，要么reject/transfer, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da445615235, createdName=ms3000000389846462, createdTime=Wed Sep 14 21:54:55 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234996, encodeId=ff93123499659, content=请问，submitted to the journal 需要几天才能改变状态？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Wed Jul 27 08:44:41 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234567, encodeId=a0fb123456e1b, content=请问，submitted to the journal 需要几天呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Mon Jul 25 11:30:44 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055110, encodeId=4df21055110f6, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：核膜;血管新生 经验分享：做蛋白新表型研究的，也有敲除动物，个人觉得做得蛮全面的，就是深度可能不够。 审稿速度正常，投稿到有review意见1个半月。 两个review细致专业，给的意见估计是大修，第二个review明显态度很积极。一共5页审稿意见，有一些也不难补，有一些是表述问题，不需要补实验。但editor估计没仔细看，就觉得要补的太多，没给机会。 所以感觉对国人不太友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23305505580, createdName=ms3000001738384174, createdTime=Sun Sep 26 20:54:06 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013517, encodeId=59fd101351e6a, content=没投过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb672316488, createdName=1223a67dm56(暂无昵称), createdTime=Wed Sep 01 17:06:03 CST 2021, time=2021-09-01, status=1, ipAttribution=)]

2024-02-26 ms4000000389646164 来自浙江省

no

1 0

[GetPortalCommentsPageByObjectIdResponse(id=799498, encodeId=b82ae9949840, content=请问这个杂志，编辑修改了格式错误，再次提交要多久能到编辑手里？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Tue Jun 23 21:21:38 CST 2020, time=2020-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189423, encodeId=3331218942342, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:31:22 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2189422, encodeId=8f662189422c1, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:30:58 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2188268, encodeId=fb5d2188268e4, content=请问大家，这个杂志有几个reviewer , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53008499251, createdName=ms2000000711984129, createdTime=Tue Feb 20 10:33:54 CST 2024, time=2024-02-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2107698, encodeId=9864210e698c3, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：细胞;分子生物;肌肉 经验分享：2022-10-30 submission 2022-10-31 with editor 2022-11-9 under review 2022-12-6 Minor revision, 2022-12-16 revised 2022-12-19 accept 审稿人意见很精辟，对内容把控的也很细致, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1de26577218, createdName=ms3000001732307962, createdTime=Tue Dec 27 17:28:23 CST 2022, time=2022-12-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1248958, encodeId=1da1124895855, content=9.9 submission，9.12 with editor，目前还没有变化，希望在编辑手里一周能出结果，要么under review，要么reject/transfer, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da445615235, createdName=ms3000000389846462, createdTime=Wed Sep 14 21:54:55 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234996, encodeId=ff93123499659, content=请问，submitted to the journal 需要几天才能改变状态？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Wed Jul 27 08:44:41 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234567, encodeId=a0fb123456e1b, content=请问，submitted to the journal 需要几天呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Mon Jul 25 11:30:44 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055110, encodeId=4df21055110f6, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：核膜;血管新生 经验分享：做蛋白新表型研究的，也有敲除动物，个人觉得做得蛮全面的，就是深度可能不够。 审稿速度正常，投稿到有review意见1个半月。 两个review细致专业，给的意见估计是大修，第二个review明显态度很积极。一共5页审稿意见，有一些也不难补，有一些是表述问题，不需要补实验。但editor估计没仔细看，就觉得要补的太多，没给机会。 所以感觉对国人不太友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23305505580, createdName=ms3000001738384174, createdTime=Sun Sep 26 20:54:06 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013517, encodeId=59fd101351e6a, content=没投过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb672316488, createdName=1223a67dm56(暂无昵称), createdTime=Wed Sep 01 17:06:03 CST 2021, time=2021-09-01, status=1, ipAttribution=)]

2024-02-26 ms4000000389646164 来自浙江省

no

15 0

[GetPortalCommentsPageByObjectIdResponse(id=799498, encodeId=b82ae9949840, content=请问这个杂志，编辑修改了格式错误，再次提交要多久能到编辑手里？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Tue Jun 23 21:21:38 CST 2020, time=2020-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189423, encodeId=3331218942342, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:31:22 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2189422, encodeId=8f662189422c1, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:30:58 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2188268, encodeId=fb5d2188268e4, content=请问大家，这个杂志有几个reviewer , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53008499251, createdName=ms2000000711984129, createdTime=Tue Feb 20 10:33:54 CST 2024, time=2024-02-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2107698, encodeId=9864210e698c3, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：细胞;分子生物;肌肉 经验分享：2022-10-30 submission 2022-10-31 with editor 2022-11-9 under review 2022-12-6 Minor revision, 2022-12-16 revised 2022-12-19 accept 审稿人意见很精辟，对内容把控的也很细致, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1de26577218, createdName=ms3000001732307962, createdTime=Tue Dec 27 17:28:23 CST 2022, time=2022-12-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1248958, encodeId=1da1124895855, content=9.9 submission，9.12 with editor，目前还没有变化，希望在编辑手里一周能出结果，要么under review，要么reject/transfer, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da445615235, createdName=ms3000000389846462, createdTime=Wed Sep 14 21:54:55 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234996, encodeId=ff93123499659, content=请问，submitted to the journal 需要几天才能改变状态？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Wed Jul 27 08:44:41 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234567, encodeId=a0fb123456e1b, content=请问，submitted to the journal 需要几天呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Mon Jul 25 11:30:44 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055110, encodeId=4df21055110f6, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：核膜;血管新生 经验分享：做蛋白新表型研究的，也有敲除动物，个人觉得做得蛮全面的，就是深度可能不够。 审稿速度正常，投稿到有review意见1个半月。 两个review细致专业，给的意见估计是大修，第二个review明显态度很积极。一共5页审稿意见，有一些也不难补，有一些是表述问题，不需要补实验。但editor估计没仔细看，就觉得要补的太多，没给机会。 所以感觉对国人不太友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23305505580, createdName=ms3000001738384174, createdTime=Sun Sep 26 20:54:06 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013517, encodeId=59fd101351e6a, content=没投过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb672316488, createdName=1223a67dm56(暂无昵称), createdTime=Wed Sep 01 17:06:03 CST 2021, time=2021-09-01, status=1, ipAttribution=)]

2024-02-20 ms2000000711984129 来自广东省

请问大家，这个杂志有几个reviewer

17 0

[GetPortalCommentsPageByObjectIdResponse(id=799498, encodeId=b82ae9949840, content=请问这个杂志，编辑修改了格式错误，再次提交要多久能到编辑手里？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Tue Jun 23 21:21:38 CST 2020, time=2020-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189423, encodeId=3331218942342, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:31:22 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2189422, encodeId=8f662189422c1, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:30:58 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2188268, encodeId=fb5d2188268e4, content=请问大家，这个杂志有几个reviewer , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53008499251, createdName=ms2000000711984129, createdTime=Tue Feb 20 10:33:54 CST 2024, time=2024-02-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2107698, encodeId=9864210e698c3, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：细胞;分子生物;肌肉 经验分享：2022-10-30 submission 2022-10-31 with editor 2022-11-9 under review 2022-12-6 Minor revision, 2022-12-16 revised 2022-12-19 accept 审稿人意见很精辟，对内容把控的也很细致, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1de26577218, createdName=ms3000001732307962, createdTime=Tue Dec 27 17:28:23 CST 2022, time=2022-12-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1248958, encodeId=1da1124895855, content=9.9 submission，9.12 with editor，目前还没有变化，希望在编辑手里一周能出结果，要么under review，要么reject/transfer, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da445615235, createdName=ms3000000389846462, createdTime=Wed Sep 14 21:54:55 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234996, encodeId=ff93123499659, content=请问，submitted to the journal 需要几天才能改变状态？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Wed Jul 27 08:44:41 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234567, encodeId=a0fb123456e1b, content=请问，submitted to the journal 需要几天呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Mon Jul 25 11:30:44 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055110, encodeId=4df21055110f6, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：核膜;血管新生 经验分享：做蛋白新表型研究的，也有敲除动物，个人觉得做得蛮全面的，就是深度可能不够。 审稿速度正常，投稿到有review意见1个半月。 两个review细致专业，给的意见估计是大修，第二个review明显态度很积极。一共5页审稿意见，有一些也不难补，有一些是表述问题，不需要补实验。但editor估计没仔细看，就觉得要补的太多，没给机会。 所以感觉对国人不太友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23305505580, createdName=ms3000001738384174, createdTime=Sun Sep 26 20:54:06 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013517, encodeId=59fd101351e6a, content=没投过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb672316488, createdName=1223a67dm56(暂无昵称), createdTime=Wed Sep 01 17:06:03 CST 2021, time=2021-09-01, status=1, ipAttribution=)]

2022-12-27 ms3000001732307962 来自湖北省

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：细胞;分子生物;肌肉
经验分享：2022-10-30 submission
2022-10-31 with editor
2022-11-9 under review
2022-12-6 Minor revision,
2022-12-16 revised
2022-12-19 accept
审稿人意见很精辟，对内容把控的也很细致

49 0

[GetPortalCommentsPageByObjectIdResponse(id=799498, encodeId=b82ae9949840, content=请问这个杂志，编辑修改了格式错误，再次提交要多久能到编辑手里？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Tue Jun 23 21:21:38 CST 2020, time=2020-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189423, encodeId=3331218942342, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:31:22 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2189422, encodeId=8f662189422c1, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:30:58 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2188268, encodeId=fb5d2188268e4, content=请问大家，这个杂志有几个reviewer , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53008499251, createdName=ms2000000711984129, createdTime=Tue Feb 20 10:33:54 CST 2024, time=2024-02-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2107698, encodeId=9864210e698c3, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：细胞;分子生物;肌肉 经验分享：2022-10-30 submission 2022-10-31 with editor 2022-11-9 under review 2022-12-6 Minor revision, 2022-12-16 revised 2022-12-19 accept 审稿人意见很精辟，对内容把控的也很细致, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1de26577218, createdName=ms3000001732307962, createdTime=Tue Dec 27 17:28:23 CST 2022, time=2022-12-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1248958, encodeId=1da1124895855, content=9.9 submission，9.12 with editor，目前还没有变化，希望在编辑手里一周能出结果，要么under review，要么reject/transfer, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da445615235, createdName=ms3000000389846462, createdTime=Wed Sep 14 21:54:55 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234996, encodeId=ff93123499659, content=请问，submitted to the journal 需要几天才能改变状态？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Wed Jul 27 08:44:41 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234567, encodeId=a0fb123456e1b, content=请问，submitted to the journal 需要几天呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Mon Jul 25 11:30:44 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055110, encodeId=4df21055110f6, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：核膜;血管新生 经验分享：做蛋白新表型研究的，也有敲除动物，个人觉得做得蛮全面的，就是深度可能不够。 审稿速度正常，投稿到有review意见1个半月。 两个review细致专业，给的意见估计是大修，第二个review明显态度很积极。一共5页审稿意见，有一些也不难补，有一些是表述问题，不需要补实验。但editor估计没仔细看，就觉得要补的太多，没给机会。 所以感觉对国人不太友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23305505580, createdName=ms3000001738384174, createdTime=Sun Sep 26 20:54:06 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013517, encodeId=59fd101351e6a, content=没投过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb672316488, createdName=1223a67dm56(暂无昵称), createdTime=Wed Sep 01 17:06:03 CST 2021, time=2021-09-01, status=1, ipAttribution=)]

2022-09-14 ms3000000389846462

9.9 submission，9.12 with editor，目前还没有变化，希望在编辑手里一周能出结果，要么under review，要么reject/transfer

94 0

[GetPortalCommentsPageByObjectIdResponse(id=799498, encodeId=b82ae9949840, content=请问这个杂志，编辑修改了格式错误，再次提交要多久能到编辑手里？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Tue Jun 23 21:21:38 CST 2020, time=2020-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189423, encodeId=3331218942342, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:31:22 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2189422, encodeId=8f662189422c1, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:30:58 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2188268, encodeId=fb5d2188268e4, content=请问大家，这个杂志有几个reviewer , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53008499251, createdName=ms2000000711984129, createdTime=Tue Feb 20 10:33:54 CST 2024, time=2024-02-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2107698, encodeId=9864210e698c3, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：细胞;分子生物;肌肉 经验分享：2022-10-30 submission 2022-10-31 with editor 2022-11-9 under review 2022-12-6 Minor revision, 2022-12-16 revised 2022-12-19 accept 审稿人意见很精辟，对内容把控的也很细致, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1de26577218, createdName=ms3000001732307962, createdTime=Tue Dec 27 17:28:23 CST 2022, time=2022-12-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1248958, encodeId=1da1124895855, content=9.9 submission，9.12 with editor，目前还没有变化，希望在编辑手里一周能出结果，要么under review，要么reject/transfer, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da445615235, createdName=ms3000000389846462, createdTime=Wed Sep 14 21:54:55 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234996, encodeId=ff93123499659, content=请问，submitted to the journal 需要几天才能改变状态？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Wed Jul 27 08:44:41 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234567, encodeId=a0fb123456e1b, content=请问，submitted to the journal 需要几天呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Mon Jul 25 11:30:44 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055110, encodeId=4df21055110f6, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：核膜;血管新生 经验分享：做蛋白新表型研究的，也有敲除动物，个人觉得做得蛮全面的，就是深度可能不够。 审稿速度正常，投稿到有review意见1个半月。 两个review细致专业，给的意见估计是大修，第二个review明显态度很积极。一共5页审稿意见，有一些也不难补，有一些是表述问题，不需要补实验。但editor估计没仔细看，就觉得要补的太多，没给机会。 所以感觉对国人不太友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23305505580, createdName=ms3000001738384174, createdTime=Sun Sep 26 20:54:06 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013517, encodeId=59fd101351e6a, content=没投过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb672316488, createdName=1223a67dm56(暂无昵称), createdTime=Wed Sep 01 17:06:03 CST 2021, time=2021-09-01, status=1, ipAttribution=)]

2022-07-27 124d2c45m98暂无昵称

请问，submitted to the journal 需要几天才能改变状态？

25 0

[GetPortalCommentsPageByObjectIdResponse(id=799498, encodeId=b82ae9949840, content=请问这个杂志，编辑修改了格式错误，再次提交要多久能到编辑手里？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Tue Jun 23 21:21:38 CST 2020, time=2020-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189423, encodeId=3331218942342, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:31:22 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2189422, encodeId=8f662189422c1, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:30:58 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2188268, encodeId=fb5d2188268e4, content=请问大家，这个杂志有几个reviewer , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53008499251, createdName=ms2000000711984129, createdTime=Tue Feb 20 10:33:54 CST 2024, time=2024-02-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2107698, encodeId=9864210e698c3, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：细胞;分子生物;肌肉 经验分享：2022-10-30 submission 2022-10-31 with editor 2022-11-9 under review 2022-12-6 Minor revision, 2022-12-16 revised 2022-12-19 accept 审稿人意见很精辟，对内容把控的也很细致, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1de26577218, createdName=ms3000001732307962, createdTime=Tue Dec 27 17:28:23 CST 2022, time=2022-12-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1248958, encodeId=1da1124895855, content=9.9 submission，9.12 with editor，目前还没有变化，希望在编辑手里一周能出结果，要么under review，要么reject/transfer, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da445615235, createdName=ms3000000389846462, createdTime=Wed Sep 14 21:54:55 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234996, encodeId=ff93123499659, content=请问，submitted to the journal 需要几天才能改变状态？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Wed Jul 27 08:44:41 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234567, encodeId=a0fb123456e1b, content=请问，submitted to the journal 需要几天呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Mon Jul 25 11:30:44 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055110, encodeId=4df21055110f6, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：核膜;血管新生 经验分享：做蛋白新表型研究的，也有敲除动物，个人觉得做得蛮全面的，就是深度可能不够。 审稿速度正常，投稿到有review意见1个半月。 两个review细致专业，给的意见估计是大修，第二个review明显态度很积极。一共5页审稿意见，有一些也不难补，有一些是表述问题，不需要补实验。但editor估计没仔细看，就觉得要补的太多，没给机会。 所以感觉对国人不太友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23305505580, createdName=ms3000001738384174, createdTime=Sun Sep 26 20:54:06 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013517, encodeId=59fd101351e6a, content=没投过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb672316488, createdName=1223a67dm56(暂无昵称), createdTime=Wed Sep 01 17:06:03 CST 2021, time=2021-09-01, status=1, ipAttribution=)]

2022-07-25 124d2c45m98暂无昵称

请问，submitted to the journal 需要几天呀

35 0

[GetPortalCommentsPageByObjectIdResponse(id=799498, encodeId=b82ae9949840, content=请问这个杂志，编辑修改了格式错误，再次提交要多久能到编辑手里？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Tue Jun 23 21:21:38 CST 2020, time=2020-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189423, encodeId=3331218942342, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:31:22 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2189422, encodeId=8f662189422c1, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:30:58 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2188268, encodeId=fb5d2188268e4, content=请问大家，这个杂志有几个reviewer , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53008499251, createdName=ms2000000711984129, createdTime=Tue Feb 20 10:33:54 CST 2024, time=2024-02-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2107698, encodeId=9864210e698c3, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：细胞;分子生物;肌肉 经验分享：2022-10-30 submission 2022-10-31 with editor 2022-11-9 under review 2022-12-6 Minor revision, 2022-12-16 revised 2022-12-19 accept 审稿人意见很精辟，对内容把控的也很细致, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1de26577218, createdName=ms3000001732307962, createdTime=Tue Dec 27 17:28:23 CST 2022, time=2022-12-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1248958, encodeId=1da1124895855, content=9.9 submission，9.12 with editor，目前还没有变化，希望在编辑手里一周能出结果，要么under review，要么reject/transfer, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da445615235, createdName=ms3000000389846462, createdTime=Wed Sep 14 21:54:55 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234996, encodeId=ff93123499659, content=请问，submitted to the journal 需要几天才能改变状态？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Wed Jul 27 08:44:41 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234567, encodeId=a0fb123456e1b, content=请问，submitted to the journal 需要几天呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Mon Jul 25 11:30:44 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055110, encodeId=4df21055110f6, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：核膜;血管新生 经验分享：做蛋白新表型研究的，也有敲除动物，个人觉得做得蛮全面的，就是深度可能不够。 审稿速度正常，投稿到有review意见1个半月。 两个review细致专业，给的意见估计是大修，第二个review明显态度很积极。一共5页审稿意见，有一些也不难补，有一些是表述问题，不需要补实验。但editor估计没仔细看，就觉得要补的太多，没给机会。 所以感觉对国人不太友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23305505580, createdName=ms3000001738384174, createdTime=Sun Sep 26 20:54:06 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013517, encodeId=59fd101351e6a, content=没投过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb672316488, createdName=1223a67dm56(暂无昵称), createdTime=Wed Sep 01 17:06:03 CST 2021, time=2021-09-01, status=1, ipAttribution=)]

2021-09-26 ms3000001738384174

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：核膜;血管新生
经验分享：做蛋白新表型研究的，也有敲除动物，个人觉得做得蛮全面的，就是深度可能不够。
审稿速度正常，投稿到有review意见1个半月。
两个review细致专业，给的意见估计是大修，第二个review明显态度很积极。一共5页审稿意见，有一些也不难补，有一些是表述问题，不需要补实验。但editor估计没仔细看，就觉得要补的太多，没给机会。
所以感觉对国人不太友好。

61 0

[GetPortalCommentsPageByObjectIdResponse(id=799498, encodeId=b82ae9949840, content=请问这个杂志，编辑修改了格式错误，再次提交要多久能到编辑手里？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Tue Jun 23 21:21:38 CST 2020, time=2020-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189423, encodeId=3331218942342, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:31:22 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2189422, encodeId=8f662189422c1, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:30:58 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2188268, encodeId=fb5d2188268e4, content=请问大家，这个杂志有几个reviewer , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53008499251, createdName=ms2000000711984129, createdTime=Tue Feb 20 10:33:54 CST 2024, time=2024-02-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2107698, encodeId=9864210e698c3, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：细胞;分子生物;肌肉 经验分享：2022-10-30 submission 2022-10-31 with editor 2022-11-9 under review 2022-12-6 Minor revision, 2022-12-16 revised 2022-12-19 accept 审稿人意见很精辟，对内容把控的也很细致, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1de26577218, createdName=ms3000001732307962, createdTime=Tue Dec 27 17:28:23 CST 2022, time=2022-12-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1248958, encodeId=1da1124895855, content=9.9 submission，9.12 with editor，目前还没有变化，希望在编辑手里一周能出结果，要么under review，要么reject/transfer, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da445615235, createdName=ms3000000389846462, createdTime=Wed Sep 14 21:54:55 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234996, encodeId=ff93123499659, content=请问，submitted to the journal 需要几天才能改变状态？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Wed Jul 27 08:44:41 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234567, encodeId=a0fb123456e1b, content=请问，submitted to the journal 需要几天呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Mon Jul 25 11:30:44 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055110, encodeId=4df21055110f6, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：核膜;血管新生 经验分享：做蛋白新表型研究的，也有敲除动物，个人觉得做得蛮全面的，就是深度可能不够。 审稿速度正常，投稿到有review意见1个半月。 两个review细致专业，给的意见估计是大修，第二个review明显态度很积极。一共5页审稿意见，有一些也不难补，有一些是表述问题，不需要补实验。但editor估计没仔细看，就觉得要补的太多，没给机会。 所以感觉对国人不太友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23305505580, createdName=ms3000001738384174, createdTime=Sun Sep 26 20:54:06 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013517, encodeId=59fd101351e6a, content=没投过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb672316488, createdName=1223a67dm56(暂无昵称), createdTime=Wed Sep 01 17:06:03 CST 2021, time=2021-09-01, status=1, ipAttribution=)]

2021-09-01 1223a67dm56(暂无昵称)

没投过

60 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务